FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067575792> ?p ?o ?g. }

• W2067575792 endingPage "1258" @default.
• W2067575792 startingPage "1250" @default.
• W2067575792 abstract "Excimer laser-derived 308-nm ultraviolet (UV) B therapy is a new alternative for treating psoriasis by phototherapy. Some studies have been made showing the effectiveness of intralesional phototherapy technology in treating psoriasis. However, there has been no information available so far with regard to the cumulative dosage on a larger group of patients and on therapy optimized treatment strategies.One hundred and twenty psoriatic patients were treated according to standard protocol to define the effectiveness. Our aim was to develop new parameters and determine whether effectiveness could be improved and whether treatment exposure, the cumulative UVB dose and adverse effects could be minimized.Initially, the excimer laser's effectiveness in treating psoriasis was evaluated in an open prospective study according to standard protocol. This included 120 adult patients (67 female/53 male) with chronic plaque psoriasis and < 20% involved body surface. The initial dose was based on three multiples of a predetermined minimal erythema dose (MED). Patients were treated twice a week for the first 3 weeks, then once a week until clearance was achieved. The main parameters were the initial starting dose, psoriasis area and severity index (PASI), the number of treatments needed, the time in treatment and the cumulative dose needed to clear psoriatic plaques. Thereafter, 43 patients were treated as a second comparable group. Therapy began with a starter dose, defined as MED-I. MED-I was defined as a UVB 308-nm dose which provoked a visible increase in erythema after 24 h. In addition, the epidermal thickness of the plaques was measured on an individual basis by 20-MHz ultrasound and correlated to the MED-I.Of the patients who met the standard protocol, 65.7% were at least 90% clear after a maximum of 10 treatments; an even greater number (85.3%) showed a > or = 90% improvement in PASI after 13 sessions, while 14.7% of patients had only a < or = 50% PASI improvement. The cumulative UVB dose was 11.25 +/- 4.21 J cm-2 and the average treatment time was 7.2 weeks. Patients treated individually with the MED-I starter dose showed nearly identical rates of clearance (83.7%), but were clear in 7.07 +/- 2.15 sessions with a cumulative dose of 6.25 +/- 4.02 J cm-2.The majority of our patients benefited greatly from laser-derived 308-nm UVB therapy, which cleared skin lesions faster than conventional phototherapy. As this therapy targets only the involved skin, the thickness of the plaques and individual MED-I should determine the initial dose, thus increasing the effectiveness of the therapy. We propose that light therapy sparing uninvolved skin will become predominant in the future." @default.
• W2067575792 created "2016-06-24" @default.
• W2067575792 creator A5014542565 @default.
• W2067575792 creator A5040177328 @default.
• W2067575792 creator A5052598507 @default.
• W2067575792 creator A5067664388 @default.
• W2067575792 creator A5071936586 @default.
• W2067575792 date "2003-12-01" @default.
• W2067575792 modified "2023-09-26" @default.
• W2067575792 title "Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach" @default.
• W2067575792 cites W1980713117 @default.
• W2067575792 cites W1984922255 @default.
• W2067575792 cites W2016087238 @default.
• W2067575792 cites W2023561417 @default.
• W2067575792 cites W2033963356 @default.
• W2067575792 cites W2050002063 @default.
• W2067575792 cites W2051522679 @default.
• W2067575792 cites W2051866603 @default.
• W2067575792 cites W2055548384 @default.
• W2067575792 cites W2056837892 @default.
• W2067575792 cites W2062074234 @default.
• W2067575792 cites W2062699716 @default.
• W2067575792 cites W2063440324 @default.
• W2067575792 cites W2064140823 @default.
• W2067575792 cites W2077893428 @default.
• W2067575792 cites W2081119960 @default.
• W2067575792 cites W2088860444 @default.
• W2067575792 cites W2093203052 @default.
• W2067575792 cites W2097200436 @default.
• W2067575792 cites W2117646004 @default.
• W2067575792 cites W2121698961 @default.
• W2067575792 cites W2127061621 @default.
• W2067575792 cites W2142653395 @default.
• W2067575792 cites W2151261149 @default.
• W2067575792 cites W2155691943 @default.
• W2067575792 cites W2170740909 @default.
• W2067575792 cites W3022667797 @default.
• W2067575792 cites W4249804296 @default.
• W2067575792 doi "https://doi.org/10.1111/j.1365-2133.2003.05709.x" @default.
• W2067575792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14674904" @default.
• W2067575792 hasPublicationYear "2003" @default.
• W2067575792 type Work @default.
• W2067575792 sameAs 2067575792 @default.
• W2067575792 citedByCount "76" @default.
• W2067575792 countsByYear W20675757922012 @default.
• W2067575792 countsByYear W20675757922013 @default.
• W2067575792 countsByYear W20675757922014 @default.
• W2067575792 countsByYear W20675757922015 @default.
• W2067575792 countsByYear W20675757922016 @default.
• W2067575792 countsByYear W20675757922017 @default.
• W2067575792 countsByYear W20675757922018 @default.
• W2067575792 countsByYear W20675757922019 @default.
• W2067575792 countsByYear W20675757922020 @default.
• W2067575792 countsByYear W20675757922021 @default.
• W2067575792 countsByYear W20675757922022 @default.
• W2067575792 countsByYear W20675757922023 @default.
• W2067575792 crossrefType "journal-article" @default.
• W2067575792 hasAuthorship W2067575792A5014542565 @default.
• W2067575792 hasAuthorship W2067575792A5040177328 @default.
• W2067575792 hasAuthorship W2067575792A5052598507 @default.
• W2067575792 hasAuthorship W2067575792A5067664388 @default.
• W2067575792 hasAuthorship W2067575792A5071936586 @default.
• W2067575792 hasConcept C126322002 @default.
• W2067575792 hasConcept C141071460 @default.
• W2067575792 hasConcept C151032500 @default.
• W2067575792 hasConcept C16005928 @default.
• W2067575792 hasConcept C197934379 @default.
• W2067575792 hasConcept C2777011040 @default.
• W2067575792 hasConcept C2779121184 @default.
• W2067575792 hasConcept C2780564577 @default.
• W2067575792 hasConcept C71924100 @default.
• W2067575792 hasConceptScore W2067575792C126322002 @default.
• W2067575792 hasConceptScore W2067575792C141071460 @default.
• W2067575792 hasConceptScore W2067575792C151032500 @default.
• W2067575792 hasConceptScore W2067575792C16005928 @default.
• W2067575792 hasConceptScore W2067575792C197934379 @default.
• W2067575792 hasConceptScore W2067575792C2777011040 @default.
• W2067575792 hasConceptScore W2067575792C2779121184 @default.
• W2067575792 hasConceptScore W2067575792C2780564577 @default.
• W2067575792 hasConceptScore W2067575792C71924100 @default.
• W2067575792 hasIssue "6" @default.
• W2067575792 hasLocation W20675757921 @default.
• W2067575792 hasLocation W20675757922 @default.
• W2067575792 hasOpenAccess W2067575792 @default.
• W2067575792 hasPrimaryLocation W20675757921 @default.
• W2067575792 hasRelatedWork W1964972042 @default.
• W2067575792 hasRelatedWork W1989170203 @default.
• W2067575792 hasRelatedWork W2032633556 @default.
• W2067575792 hasRelatedWork W2039876145 @default.
• W2067575792 hasRelatedWork W2390441009 @default.
• W2067575792 hasRelatedWork W2390472152 @default.
• W2067575792 hasRelatedWork W2587864234 @default.
• W2067575792 hasRelatedWork W2781166685 @default.
• W2067575792 hasRelatedWork W2898213950 @default.
• W2067575792 hasRelatedWork W3022724713 @default.
• W2067575792 hasVolume "149" @default.
• W2067575792 isParatext "false" @default.
• W2067575792 isRetracted "false" @default.

• next